µ¼Ê¦ÐÕÃû£º¹¨¹úÇå
ÐÔ±ð£ºÄÐ
ÈËÆøÖ¸Êý£º86
ËùÊôԺУ£ºÖйúÒ©¿Æ´óѧ
ËùÊôԺϵ£ºÒ©Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÒ©Àíѧ
Ñо¿ÁìÓò£º Éú»¯Ò©Àí¡£
Ñо¿ÁìÓò£º Éú»¯Ò©Àí¡£ [ÊÕÆð]
ͨѶ·½Ê½ :
°ì¹«µç»°£º**
µç×ÓÓʼþ£ºgonggq@hotmail.com
¸öÈ˼òÊö :
¹¨¹úÇå? ÄУ¬1966Äê8ÔÂÉú¡£1987ÄêÖйúÒ©¿Æ´óѧҩÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔر¾¿Æ±ÏÒµ£¬1990Äê»ñÒ©ÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔØ˶ʿѧ룬2004Äê»ñµÃÒ©Àíѧ²©Ê¿Ñ§Î»¡£ÏÖÈÎҩѧԺҩÀí½ÌÑÐÊÒ¸±½ÌÊÚ£¬Ò©Ñ§Ò½Ñ§»ù´¡ÊµÑéÖÐÐĸ±Ö÷ÈΡ£½üÄêÀ´²ÎÓëÍê³É¹ú¼Ò×ÔÈ»»ù½ðÏîÄ¿2Ï¹ú¼Ò¿Æ¼¼²¿ÐÂÒ©´´ÖÆÖØ´óרÏî2Ï·¢±íSCIÂÛÎÄ10Óàƪ£»²ÎÓëÉêÇëµÄ·¢Ã÷רÀû6ÏÆäÖÐÒÑÊÚȨרÀû2Ïî¡£ Ä¿Ç°Ö÷³Ö¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð1ÏÑо¿´´ÐÂÒ©ÎïµÄ¿¹ÑªË¨¶à°Ðµã×÷Ó÷Ö×Ó»úÖÆ£»²ÎÓë¹ú¼Ò×ÔÈ»¿Æѧ»ù½ð2Ï¿Æ¼¼²¿ÐÂÒ©´´ÖÆÖØ´óרÏî2Ïî¡£
¿ÆÑй¤×÷ :
½üÄê·¢±íµÄÖ÷ÒªÎÄÕ£º
1. Shaochi Wang, Peng Dai, Yungen Xu, Qiufang Chen, Qihua Zhu, Guoqing Gong*£¨Í¨Ñ¶×÷Õߣ©Design, Synthesis, and Biological Evaluation of DabigatranEtexilate Mimics, A Novel Class of Thrombin Inhibitors Arch. Pharm. Chem. Life Sci. 2015, 348, 595-6052. Mei-Ling Jiang, Zhi-Xian Zhang, Yun-Zhan Li , Xin-Hui Wang, Wei Yan, Guo-Qing Gong*£¨Í¨Ñ¶×÷Õߣ© Antidepressant-like effect of evodiamine on chronic unpredictable mild stress rats Neuroscience Letters 588 (2015) 154-1583. Yun Yang , Xinhui Wang , Qihua Zhu , Guoqing Gong *£¨Í¨Ñ¶×÷Õߣ©, Danmeng Luo , Aidou Jiang , Liyan Yang ,Yungen Xu , Synthesis and pharmacological evaluation of novel limonin derivatives as anti-inflammatory and analgesic agents with high water solubility Bioorganic & Medicinal Chemistry Letters 24 (2014) 1851-18554. Xinhui Wang, Guoqing Gong*£¨Í¨Ñ¶×÷Õߣ©, Wenhui Yang, Yunzhan Li, Meiling Jiang, Linlin Li Antifibrotic activity of galangin, a novel function evaluated in animal liver fibrosis model Environmental Toxicology and Pharmacology 36(2013)288-2955. Yun-Zhan Li , Guo-Qing Gong *£¨Í¨Ñ¶×÷Õߣ©, Wen-Hui Yang , Xin-Hui Wang , Mei-Ling Jiang , Yi Zhou ,Xiao-Zhi Yang , Yun-Gen Xu , Guang-Wei He Antithrombotic activity of HY023016, a novel Dabigatran prodrug evaluated in animal thrombosis models Thrombosis Research 131 (2013) 425-4356. Yi Zhou, Guoqing Gong*£¨Í¨Ñ¶×÷Õߣ©, Wenhui Yang, Yin Wang, Jing Xu, Yungen Xu The cardioprotective effect of TG-6, a newly synthesized compound, on ischemia-reperfusion injury in rats European Journal of Pharmacology 683 (2012) 190-1967. Xiao-Zhi Yang, Wen-Hui Yang , Yun-Gen Xu* , Xiao-Juan Diao, Guo-qing Gong**£¨Í¨Ñ¶×÷Õߣ© Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activitys European Journal of Medicinal Chemistry 57 (2012) 21-288. Lu Jin, Xiang-Min Jiang, Ping Du, Jing Xu, Guo-qing Gong**(ͨѶ×÷Õß), Qiu-juan Wang, Yun-gen Xu* Synthesis and Na+/H+ exchanger inhibitory activityof benzoylguanidine derivatives. European Journal of Medicinal Chemistry,2011,46:4107-4116
½ÌÓý±³¾° :
1987ÄêÖйúÒ©¿Æ´óѧҩÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔر¾¿Æ±ÏÒµ£¬1990Äê»ñÒ©ÀíöλÔÓéÀֵǼÈë¿ÚÏÂÔØ˶ʿѧ룬2004Äê»ñµÃÒ©Àíѧ²©Ê¿Ñ§Î»¡£
ÖйúÒ©¿Æ´óѧöλÔÓéÀÖ¹Ù·½appÏÂÔØÑо¿Éúµ¼Ê¦¼ò½é-¹¨¹úÇå
±¾Õ¾Ð¡±à FreeöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-05-27
Ïà¹Ø»°Ìâ/Ò©Àí Ò©Àíѧ ˶ʿѧλ ²©Ê¿Ñ§Î» ÐÂÒ©
ÁìÏÞʱ´ó¶îÓÅ»Ýȯ,Ïí±¾Õ¾Õý°æöλÔÓéÀֵǼÈë¿ÚÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ!
ÓÅ»ÝȯÁìÈ¡ºó72СʱÄÚÓÐЧ£¬10ÍòÖÖ×îÐÂöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿¼Ö¤Ààµç×Ó´òÓ¡öλÔÓéÀÖ¹Ù·½appÏÂÔØÈÎÄãÑ¡¡£º¸ÇÈ«¹ú500ÓàËùԺУöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀֵǼÈë¿ÚÏÂÔؿΡ¢200¶àÖÖÖ°Òµ×ʸñöλÔÓéÀֵǼÈë¿ÚÏÂÔØ¡¢1100¶àÖÖ¾µä½Ì²Ä£¬²úÆ·ÀàÐÍ°üº¬µç×ÓÊé¡¢Ìâ¿â¡¢È«Ì×öλÔÓéÀÖ¹Ù·½appÏÂÔØÒÔ¼°ÊÓƵ£¬ÎÞÂÛÄúÊÇöλÔÓéÀÖ¹Ù·½appÏÂÔظ´Ï°¡¢¿¼Ö¤Ë¢Ì⣬»¹ÊÇ¿¼Ç°³å´ÌµÈ£¬²»Í¬ÀàÐ͵IJúÆ·¿ÉÂú×ãÄúѧϰÉϵIJ»Í¬ÐèÇó¡£ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØÓÅ»Ýȯ ±¾Õ¾Ð¡±à FreeÒ¼°Û·ÖѧϰÍø 2022-09-19Ò©Àíѧ±¾¿Æ¸´Ï°Ìâ(¾«Ñ¡)ÆÚÄ©¸´Ï°Ìâ
Ò©Àíѧ¸´Ï°Ì⣨¾«Ñ¡£© µÚÒ»Õ Ð÷ ÑÔ Ò»¡¢Ñ¡ÔñÌ⣺ AÐÍÌâ 1¡¢Ò©Ð§Ñ§Ö÷ÒªÊÇÑо¿£º A Ò©ÎïÔÚÌåÄڵı仯¼°Æä¹æÂÉ B Ò©ÎïÔÚÌåÄÚµÄÎüÊÕ C Ò©Îï¶Ô»úÌåµÄ×÷Óü°Æä¹æÂÉ D Ò©ÎïµÄÁÙ´²ÁÆЧ E Ò©ÎïÁÆЧµÄÓ°ÏìÒòËØ ²Î¿¼´ð°¸£º Ò»¡¢Ñ¡ÔñÌ⣺ AÐÍÌ⣺1.C µÚ¶þÕ ҩÎïЧӦ¶¯Á¦Ñ§ Ò»¡¢Ñ¡ÔñÌ⣺ AÐÍÌâ ...öλÔÓéÀֵǼÈë¿ÚÏÂÔØ¿ÎöλÔÓéÀÖ¹Ù·½appÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2018-12-312019ÄêÖйúÒ½Ò©¹¤ÒµÑо¿×ÜÔºöλÔÓéÀÖ¹Ù·½appÏÂÔØÒ©ÀíѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØöλÔÓéÀֵǼÈë¿ÚÏÂÔØ´ó¸Ù
¾ÝÖйúÒ½Ò©¹¤ÒµÑо¿×ÜÔºÏûÏ¢£¬2019ÄêÖйúÒ½Ò©¹¤ÒµÑо¿×ÜÔºÒ©ÀíѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØöλÔÓéÀÖ¹Ù·½appÏÂÔØ´ó¸ÙÒÑ·¢²¼£¬ÏêÇéÈçÏ£º2019ÄêÖйúÒ½Ò©¹¤ÒµÑо¿×ÜԺ˶ʿÑо¿ÉúÈëѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØÒ©ÀíѧöλÔÓéÀֵǼÈë¿ÚÏÂÔØöλÔÓéÀֵǼÈë¿ÚÏÂÔØ´ó¸Ù.zip ...2023öλÔÓéÀֵǼÈë¿ÚÏÂÔؿδó¸Ù ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2018-11-04Î÷ÄÏ´óѧ2019ÄêÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲Ź¥¶Á˶ʿѧλÕÐÉúÕ³Ì
Ò»¡¢ÅàÑøÄ¿±êÅàÑø¼á¶¨µØÓµ»¤Öйú¹²²úµ³µÄÁìµ¼ºÍÉç»áÖ÷ÒåÖƶȡ¢¼á¶¨µØά»¤Ãñ×åÍŽáºÍ¹ú¼Òͳһ¡¢Á¢Ö¾ÎªÎ÷²¿´ó¿ª·¢ºÍÃñ×åµØÇø·¢Õ¹·þÎñ;ÔÚ±¾ÃÅѧ¿ÆÄÚÕÆÎÕ¼áʵµÄ»ù´¡ÀíÂÛºÍϵͳµÄרÃÅ֪ʶ£¬¾ßÓдÓÊ¿ÆѧÑо¿¡¢½Ìѧ¡¢¹ÜÀí»ò¶ÀÁ¢µ£¸º×¨Ãż¼Êõ¹¤×÷ÄÜÁ¦ºÍ´´Ð¾«ÉñµÄ¸ß¼¶×¨ÃÅÈ˲š£¶þ¡¢ÉúÔ´·¶Î§¼°ÕÐÉú¶ÔÏó1.ÉúÔ´µØÔÚÄÚÃɹš¢¹ãÎ÷¡¢ ...ÕÐÉú¼òÕ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2018-11-04ôßÄÏ´óѧ2019Äê¡°Éٸɼƻ®¡±ÕÐÊÕ¹¥¶Á˶ʿѧλÑо¿Éú¼òÕÂ
ôßÄÏ´óѧ2019ÄêÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲żƻ®ÕÐÊÕ¹¥¶Á˶ʿѧλÑо¿Éú¼òÕ¹«²¼£¬ÄÚÈÝÈçÏ£ºÎª¹á³¹Âäʵ¡¶½ÌÓý²¿¹ú¼Ò·¢Õ¹¸Ä¸ïί¹ú¼ÒÃñί²ÆÕþ²¿ÈËʲ¿¹ØÓÚ´óÁ¦ÅàÑøÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲ŵÄÒâ¼û¡·£¨½ÌÃñ¡²2004¡³5ºÅ£©¼°¡¶½ÌÓý²¿µÈÎ岿ί¹ØÓÚÓ¡·¢<ÅàÑøÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲żƻ®µÄʵʩ·½°¸ ...ÕÐÉú¼òÕ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2018-11-04¹óÖÝ´óѧ2019Äê¡°ÉٹǸÉÈ˲żƻ®¡±¹¥¶Á˶ʿѧλÑо¿Éú֪ͨ
¹óÖÝ´óѧ¹ØÓÚÕÐÊÕ2019ÄêÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲Ź¥¶Á˶ʿѧλÑо¿ÉúµÄ֪ͨ¸ù¾Ý¡¶½ÌÓý²¿°ì¹«Ìü¹ØÓÚÏ´ï2019ÄêÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲ÅÑо¿ÉúÕÐÉú¼Æ»®µÄ֪ͨ¡·(½ÌÃñÌü¡²2018¡³2ºÅ)¡¢¡¶¹óÖÝÊ¡½ÌÓýÌü°ì¹«ÊÒ¹ØÓÚ×öºÃ2019ÄêÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲ÅÑо¿Éú±¨¿¼Óйع¤×÷µÄ֪ͨ¡·Îļþ¾«Éñ£¬ÎÒУ2019ÄêÉÙÊýÃñ×å¸ß ...ÕÐÉú¼òÕ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2018-11-04ºÓÄÏ´óѧ2019ÄêÕÐÊÕ¹¥¶Á˶ʿѧλÑо¿Éú¼òÕÂ
ºÓÄÏ´óѧ´´°ìÓÚ1912Ä꣬³õÃûºÓÄÏÁôѧŷÃÀÔ¤±¸Ñ§Ð££¬Êǵ±Ê±ÎÒ¹ú³Ðµ£º£ÍâÔ¤±¸ÁôѧÉú½ÌÓýÈÎÎñµÄÈýËùѧУ֮һ¡£2017Ä꣬ºÓÄÏ´óѧ½øÈëË«Ò»Á÷½¨Éè¸ßУÐÐÁС£Ñ§Ð£ÏÖÓÐÎÄ¡¢Ê·¡¢ÕÜ¡¢¾¡¢¹Ü¡¢·¨¡¢Àí¡¢¹¤¡¢Ò½¡¢Å©¡¢½ÌÓý¡¢ÒÕÊõµÈ12¸öѧ¿ÆÃÅÀ࣬ 20¸ö²©Ê¿Ñ§Î»ÊÚȨһ¼¶Ñ§¿Æ£¬43¸ö˶ʿѧλÊÚȨ ...ÕÐÉú¼òÕ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2018-11-04ÖйúÒôÀÖѧԺ2019ÄêÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲Ź¥¶Á˶ʿѧλÕÐÉú¼òÕÂ
´ÓÖйúÒôÀÖѧԺÑо¿ÉúÔº»ñϤ£¬2019ÄêÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲Ź¥¶Á˶ʿѧλÕÐÉú¼òÕÂÒѹ«²¼£¬ÈçÏ£ºÖйúÒôÀÖѧԺ2019ÄêÉÙÊýÃñ×å¸ß²ã´Î¹Ç¸ÉÈ˲Ź¥¶Á˶ʿѧλÕÐÉú¼òÕ ...ÕÐÉú¼òÕ ±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø 2018-11-04